Radiosensitization by the mTOR inhibitor RAD001 involves the induction of autophagy in two cancer cell lines

被引：0
|
作者：
Bischoff, Pierre L. [1 ]
Altmeyer, Anais [1 ]
Josset, Elodie [1 ]
Denis, Jean -Marc [2 ]
Gueulette, John [2 ]
Slabbert, Jakobus P. [3 ]
Noel, Georges [1 ]
机构：
[1] Univ Strasbourg, Ctr Paul Strauss, EA 3430, Strasbourg, France
[2] Catholic Univ Louvain, MIRO, B-1200 Brussels, Belgium
[3] iThemba LABS, Somerset West, South Africa
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/1538-7445.AM2012-1466
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1466
引用
收藏
页数：2
相关论文
共 50 条
  • [41] The mTOR pathway inhibitor RAD001 (everolimus) is highly efficacious in tamoxifen-sensitive and -resistant breast cancer xenografts
    Behrens, Diana
    Lykkesfeldt, Anne E.
    Fichtner, Iduna
    TARGETED ONCOLOGY, 2007, 2 (03) : 135 - 144
  • [42] Metformin and the mTOR Inhibitor Everolimus (RAD001) Sensitize Breast Cancer Cells to the Cytotoxic Effect of Chemotherapeutic Drugs In Vitro
    Liu, Hongyu
    Scholz, Christian
    Zang, Chuanbing
    Schefe, Jan H.
    Habbel, Piet
    Regierer, Anne-Constanze
    Schulz, Carsten-Oliver
    Possinger, Kurt
    Eucker, Jan
    ANTICANCER RESEARCH, 2012, 32 (05) : 1627 - 1637
  • [43] Expression and activation of mTOR in neuroendocrine tumors. Effects of mTOR inhibition by RAD001 upon growth, cell cycle regulation and signalling in neuroendocrine cell lines
    Hoersch, D.
    Tielke, S.
    Schrader, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [44] Combined therapy with RAD001 e BEZ235 overcomes resistance of PET immortalized cell lines to mTOR inhibition
    Passacantilli, Ilaria
    Capurso, Gabriele
    Archibugi, Livia
    Calabretta, Sara
    Caldarola, Sara
    Loreni, Fabrizio
    Delle Fave, Gianfranco
    Sette, Claudio
    ONCOTARGET, 2014, 5 (14) : 5381 - 5391
  • [45] Biomarker Development for the Clinical Activity of the mTOR Inhibitor Everolimus (RAD001): Processes, Limitations, and Further Proposals
    O'Reilly, Terence
    McSheehy, Paul M. J.
    TRANSLATIONAL ONCOLOGY, 2010, 3 (02): : 65 - 79
  • [46] Combination of the mTOR inhibitor RAD001 with temozolomide and radiation effectively inhibits the growth of glioblastoma cells in culture
    Burckel, Helene
    Josset, Elodie
    Denis, Jean-Marc
    Gueulette, John
    Slabbert, Jakobus
    Noel, Georges
    Bischoff, Pierre
    ONCOLOGY REPORTS, 2015, 33 (01) : 471 - 477
  • [47] Phase I Trial of a Novel Combination of An HDAC Inhibitor (LBH589) and An mTOR Inhibitor (RAD001) in Lymphoid and Plasma Cell Malignancies
    Kumar, Shaji
    Mikhael, Joseph R.
    LaPlant, Betsy R.
    Colgan, Joseph P.
    Inwards, David James
    Johnston, Patrick B.
    Laumann, Kristina
    Micallef, Ivana N.
    Nowakowski, Grzegorz S.
    Ansell, Stephen M.
    Curtis, Kelly
    Dispenzieri, Angela
    Lacy, Martha Q.
    Leis, Jose F.
    Northfelt, Donald
    Reeder, Craig B.
    Slack, James L.
    Witzig, Thomas E.
    BLOOD, 2011, 118 (21) : 1152 - 1153
  • [48] INHIBITION OF AUTOPHAGY ENHANCED THE CELL DEATH INDUCING EFFECT OF EVEROLIMUS (RAD001) IN HUMAN BLADDER CANCER CELLS
    Lin, Yi-Chia
    Lin, Ji-Fan
    Tsai, Te-Fu
    Chen, Hung-En
    Chou, Kuang-Yu
    Hwang, Thomas I. S.
    JOURNAL OF UROLOGY, 2014, 191 (04): : E369 - E369
  • [49] Effect of NVPAEW541 and RAD001 on Cell Growth and Apoptosis in two Pancreatic Adenocarcinoma Cell lines.
    Warshamana-Greene, G. S.
    Panthi, A.
    MOLECULAR BIOLOGY OF THE CELL, 2016, 27
  • [50] In vivo antitumor activity of NVP-BEZ235, a dual PI3K/mTOR inhibitor, and RAD001 (everolimus), an mTOR inhibitor, in endometrial cancer
    Shoji, Keiko
    Oda, Katsutoshi
    Nakagawa, Shunsuke
    Ikeda, Yuji
    Kashiyama, Tomoko
    Miyamoto, Yuichiro
    Tanikawa, Michihiro
    Kuramoto, Hiroyuki
    Hiraike-Wada, Osamu
    Yano, Tetsu
    Taketani, Yuji
    CANCER RESEARCH, 2011, 71
12345